Advertisement

Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint: Canada

  • Timothy R. AsmisEmail author
  • Joel Werier
  • Shailendra Verma
Chapter
Part of the Current Clinical Oncology book series (CCO)

Abstract

Osteosarcomas are uncommon tumors that affect mainly children and adolescents. Statistics Canada estimates that 153 cases per year are diagnosed in Canadians 0–19 years old [1]. Survival has been dramatically improved through the routine use of neoadjuvant and adjuvant multidrug chemotherapy. Once multimodality therapy has been completed, surveillance commences. The goals of a surveillance program are multifactorial and include assessment of the primary tumor site for recurrence, assessment of functionality, especially when limb-sparing surgery has been employed, early detection of systemic (particularly pulmonary) metastases, and detection of treatment toxicities. Screening is defined by the National Cancer Institute as checking for disease when there are no symptoms. Since screening may find diseases at an early stage, it is hypothesized that this could improve chances for cure [2]. As a test for the presence or absence of a disease [3], screening can occur either prior to the detection of a disease (primary screening) or after a disease has been diagnosed and treated (secondary). A screening program should be effective in detecting potentially curable disease, be cost-effective, and available to patients.

Keywords

ESMO Canada Metastases Osteosarcoma Surveillance 

References

  1. 1.
    Canada S: Canadian cancer statistics. 2008Google Scholar
  2. 2.
    National Cancer Institute, Dictionary of cancer terms, 2010Google Scholar
  3. 3.
    Oxford University Press. Oxford English dictionary. Oxford, England: Oxford University Press; 2003.Google Scholar
  4. 4.
    Hogendoorn PC, Athanasou N, Bielack S, et al. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v204–13.PubMedCrossRefGoogle Scholar
  5. 5.
    DeVita VT, Rosenberg SA, Hellman S. Cancer principles and practice of oncology, Books@Ovid. 7th ed. Lippincott, Williams & Wilkins: Philadelphia; 2005.Google Scholar
  6. 6.
    Telander RL, Pairolero PC, Pritchard DJ, et al. Resection of pulmonary metastatic osteogenic sarcoma in children. Surgery. 1978;84: 335–41.PubMedGoogle Scholar
  7. 7.
    Putnam Jr JB, Roth JA, Wesley MN, et al. Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: analysis of prognostic factors. Ann Thorac Surg. 1983;36: 516–23.PubMedCrossRefGoogle Scholar
  8. 8.
    Goorin AM, Delorey MJ, Lack EE, et al. Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. J Clin Oncol. 1984;2:425–31.PubMedGoogle Scholar
  9. 9.
    Meyer WH, Schell MJ, Kumar AP, et al. Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival. Cancer. 1987;59:374–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Han MT, Telander RL, Pairolero PC, et al. Aggressive thoracotomy for pulmonary metastatic osteogenic sarcoma in children and young adolescents. J Pediatr Surg. 1981;16:928–33.PubMedCrossRefGoogle Scholar
  11. 11.
    Tronc F, Conter C, Marec-Berard P, et al. Prognostic factors and long-term results of pulmonary metastasectomy for pediatric histologies. Eur J Cardiothorac Surg. 2008;34:1240–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Harting MT, Blakely ML, Jaffe N, et al. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg. 2006;41:194–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Bielack S, Carrle D, Jost L. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19 Suppl 2:94–6.Google Scholar

Copyright information

© Humana Press 2013

Authors and Affiliations

  • Timothy R. Asmis
    • 1
    Email author
  • Joel Werier
    • 1
  • Shailendra Verma
    • 1
  1. 1.The Ottawa Hospital Regional Cancer CentreOttawaCanada

Personalised recommendations